PPD

JUNE 24, 2024

In the realm of vaccine development, mega trials — studies enrolling 5,000 subjects or more — have been instrumental in the fight against many pathogens, including influenza, rotavirus, malaria, RSV and most recently in the rapid development of vaccines against COVID-19.

Vaccine 97

Vaccine Trials Clinical Trials Laboratories 97

Drug Discovery World

APRIL 15, 2023

The American Association for Cancer Research (AACR) Annual Meeting is taking place at the Orange County Convention Center in Orlando, Florida from April 14-19, 2023. Tuesday, April 18, 2023, 9am ET Patient-derived TAC01-HER2 TAC T cells produced in Cocoon Platform are highly functional in models of solid tumors – Ling Wang, et al.

Virus 130

Virus Clinical Trials Trials Therapies 130

Drug Discovery World

DECEMBER 20, 2022

DDW’s Diana Spencer summarises the key trends likely to impact the market in 2023. . There will be greater emphasis on diversity in clinical trials. A focus on the representation of diverse patient populations in clinical trials will be a very good thing for the industry, but could be challenging.

Clinical Trials 130

Clinical Trials Drugs Trials Marketing 130

Conversations in Drug Development Trends

AUGUST 10, 2023

With so many exciting developments in the last few years, it’s critical for the psychedelic community to come together to reflect on our progress, share the latest discoveries, and discuss the future of psychedelic research. Reflecting back on my conference experience, there are three key takeaways that stand out: 1.

Science 98

Science Clinical Trials Trials Clinical Research 98

Drug Discovery World

APRIL 29, 2024

Dr Currien MacDonald, Medical Chair Director at WCG, discusses the challenges and opportunities presented by cannabis research. Research support Support for researching cannabidiol is expanding. More importantly, cannabis research received additional governmental support for continued investigation at the end of 2022 with H.R.8454,

Research 148

Research FDA Production Drug Development 148

Conversations in Drug Development Trends

JANUARY 24, 2024

Written By: Derek Ansel, MS, CCRA, Executive Director, Therapeutic Strategy Lead, Rare Disease Given that 80% of rare diseases have a genetic etiology, genetic implications should be addressed at the onset of a clinical program to support trial enrollment. One diagnostic example that I discussed in my presentation is autism.

Trials 75

Trials Disease Clinical Trials Clinical Research 75

PPD

AUGUST 16, 2023

The COVID-19 pandemic rapidly accelerated the adoption of hybrid and decentralized clinical trial (DCT) models. At the end of 2022, the PPD clinical research business of Thermo Fisher Scientific surveyed key leadership and staff on the frontline of clinical trial execution across the industry.

Clinical Trials 98

Clinical Trials Trials Clinical Research FDA 98

Fierce BioTech

NOVEMBER 2, 2023

Optimizing Clinical Trials: Getting the Right Results by Keeping it Real Discover how RWD can transform your approach to clinical trial protocol optimization, patient identification, and site selection in this survey of clinical research leaders by Flatiron Health. Download now.

Clinical Trials 52

Clinical Trials Trials Clinical Research Research 52

Drug Discovery World

JANUARY 25, 2023

Tom Brazier , Director Decentralised Clinical Trials, mdgroup and Stephanie Larimer, Q² Solutions discuss the opportunities for decentralised clinical trials and how common pitfalls can be avoided through communications and streamlined working. Direct communication is the most efficient solution.

Trials 130

Trials Clinical Trials Laboratories Nurses 130

Vial

FEBRUARY 29, 2024

Contract research organizations (CROs) are an integral partner of the drug development process, as they play a pivotal role supporting clinical trial conduct for pharmaceutical, biotechnology, and medical device sponsor companies. between 2023 and 2032. What is the Role of the Contract Research Organization (CRO)?

Clinical Trials 52

Clinical Trials Trials Clinical Research Marketing 52

Advarra

OCTOBER 19, 2023

The clinical trial startup process has seen significant shifts over the past five years: growth in decentralized trials, improved technology, and an increased demand for accelerated timelines in getting therapies to market. Each of these have contributed to a rapidly evolving clinical research landscape.

Clinical Trials 52

Clinical Trials Trials Clinical Research Research 52

Fierce BioTech

MAY 18, 2023

In this webinar we will discuss: The growing complexity of clinical research. How has clinical technology evolved over the last few years? AI, machine learning) What should we be thinking about now to improve trials for the future? On Demand Start Date Tue, 06/27/2023 - 15:00 Where are the gaps?

Clinical Trials 52

Clinical Trials Trials Clinical Research Science 52

Drug Discovery World

JUNE 9, 2023

There has been some interesting news related to clinical trials this week, with the announcement that the FDA has published draft guidance to modernise the design and conduct of studies, and the failure of Bellerophon Therapeutics’ Phase III study in fibrotic Interstitial Lung Disease.

Clinical Trials 130

Clinical Trials FDA Trials Drugs 130

Drug Discovery World

MAY 30, 2024

Dr Pollock is the Chief Investigator of the LEGACY03 clinical trial, a study aiming to investigate lymph nodes and vaccination responses across age groups. RA: Could you tell us about the LEGACY03 trial? The study will recruit 48 participants over two winter seasons in 2023-2024 and 2024-2025.

Vaccine 148

Vaccine Protein Expression Clinical Trials Immune Response 148

PPD

NOVEMBER 7, 2023

The underrepresentation of diverse groups in clinical research is an area of regulatory, scientific and industry focus, partly due to the recent U.S. Food and Drug Administration (FDA) draft guidance, “Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials.”

Clinical Trials 59

Clinical Trials Trials Clinical Research Disease 59

Conversations in Drug Development Trends

OCTOBER 24, 2023

I was honored to be invited to present a Master Class on Gene Replacement and Gene Editing at the 2023 Global Genes Advocacy Summit, an annual event attended by hundreds of rare disease patients, rare disease advocates, and rare disease drug developers. Over the years, I have attended several Global Genes Summits.

Clinical Trials 52

Clinical Trials Disease Therapies Drug Development 52

Broad Institute

OCTOBER 3, 2023

Broad Clinical Labs established to expand clinical services By Leah Eisenstadt October 3, 2023 Breadcrumb Home Broad Clinical Labs established to expand clinical services Formerly the Clinical Research Sequencing Platform, the cutting-edge laboratory at the Broad Institute is poised to further accelerate clinical genomics.

Clinical Research 131

Clinical Research Clinical Trials Laboratories Trials 131

PPD

JUNE 27, 2024

In recent years, AA has followed in the footsteps of other dermatology indications — including psoriasis and atopic dermatitis — with growing research and clinical studies focusing on small molecules with broad cellular effects (JAK and PDE4 inhibitors) and cytokine-specific molecules antagonists (IL-23, Th2 and IL17) to treat the condition.

Treatment 52

Treatment Clinical Trials Small Molecule Clinical Research 52

PPD

NOVEMBER 30, 2023

As we approach the end of 2023, it’s time to reflect on the past 12 months and how advances in drug development shaped the pharma and biotech industries. These shifts are a prelude to further change and progress in the clinical trial landscape in 2024. This year, the U.S.

Clinical Trials 98

Clinical Trials Trials Clinical Research Drug Development 98

Conversations in Drug Development Trends

NOVEMBER 10, 2023

At this year’s annual Pain Therapeutics Summit , which took place in San Diego, CA, October 19 to 20th, I heard brilliant presentations on novel pain medication development, targeted discoveries, pain classifications, the NIH HEAL Initiative , trial designs, biomarkers, and others.

Clinical Trials 75

Clinical Trials Trials Compliance Doctors 75

Vial

MARCH 1, 2024

Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). By geographical region, the global CRO services market in 2023 was dominated by North America. billion in 2023 attributable to its laboratory products and biopharma services segment (53.8% with US$23.04

Clinical Trials 52

Clinical Trials Clinical Research Laboratories Trials 52

Precision for Medicine

MAY 24, 2023

CRO Leadership Awards recognize companies judged by customers as exceeding expectations BETHESDA, MD, May 25, 2023 – Precision for Medicine, the first biomarker-driven clinical research organization (CRO), announces its wide recognition in the 2023 CRO Leadership Awards.

Clinical Trials 40

Clinical Trials Clinical Research Science Laboratories 40

PPD

APRIL 30, 2024

31, 2022, the EU Clinical Trial Regulation (EU CTR) 536/2014 became applicable, heralding a new era for clinical trials in the European Union (EU). In addition, the constant evolution of EMA and Clinical Trials Coordination Group (CTCG) guidelines requires constant attention.

Clinical Trials 52

Clinical Trials Regulations Trials Pharmaceutical Companies 52

PPD

FEBRUARY 22, 2023

These anecdotal struggles were highlighted in industry research conducted by PPD, the clinical research business of Thermo Fisher Scientific. As we look ahead into 2023, there is still uncertainty in the funding landscape, but forecasts are improving. Three Financial Shifts Expected in the Biotech Industry in 2023 1.

Biosimilars 52

Biosimilars Clinical Research Marketing Trials 52

LifeSciVC

JULY 11, 2023

The meeting brings together tens of thousands of physicians, scientists, patients, advocates, innovators, and those involved in oncology drug development from around the world in order to explore the latest advances in cancer treatment, clinical trials, and translational and clinical research.

Therapies 67

Therapies Trials Clinical Development Science 67

Vial

MAY 28, 2024

In the rapidly expanding world of digital health, Medable and Vial CRO (Contract Research Organization) , two leading technology organizations, are revolutionizing the way clinical research is conducted.

Clinical Trials 52

Clinical Trials Clinical Research Compliance Trials 52

Alta Sciences

SEPTEMBER 13, 2023

Four Pain Models Altasciences Uses to Assess Treatments During Clinical Trials pmjackson Wed, 09/13/2023 - 17:01 September is pain awareness month, and the importance of pain management and continued research into effective analgesics is integral to helping patients suffering from various pain conditions.

Clinical Trials 52

Clinical Trials Treatment Trials Pharmacokinetics 52

Drug Discovery World

APRIL 14, 2023

The American Association for Cancer Research (AACR) will honour the following cancer researchers, physician-scientists, advocates, and journalists during its annual meeting to be held April 14-19 at the Orange County Convention Center in Orlando, Florida. June’s award lecture will be held on Sunday April 16 at 4:30pm ET.

Clinical Trials 130

Clinical Trials Research Science Clinical Research 130

Agency IQ

APRIL 12, 2024

Landscape analysis: A look at the regulation of decentralized trials and what’s coming soon In the past few years, regulators and researchers have shown increased interest in leveraging decentralized trial methods – especially following the pandemic.

Regulations 40

Regulations Trials Science Clinical Trials 40

Conversations in Drug Development Trends

DECEMBER 7, 2023

Amidst a shifting clinical landscape characterized by increasingly complex trial designs and growing patient subpopulations, many contract research organizations (CROs) have adopted a “one-stop-shop” strategic approach. What Differentiates Mid-Size CROs?

Clinical Trials 136

Clinical Trials Clinical Development Trials Pharmaceutical Companies 136

Conversations in Drug Development Trends

FEBRUARY 22, 2023

Rare Disease Day on February 28th is a chance for rare disease communities to come together as one and join in conversation with stakeholders searching for treatments, raising money to support research, and changing the way healthcare and governments interact with patients. What will have the greatest impact on rare disease patients in 2023?

Disease 52

Disease Clinical Trials Trials Treatment 52

Fierce BioTech

AUGUST 10, 2023

Sponsors and provider organizations understand that patient- and site-centricity are critical for a robust clinical trial industry. The 2023 Avoca State of the Industry Report provides a 360° view on motivators and deterrents to trial participation across clinical research stakeholders – sponsors, providers, sites, and patients

Clinical Trials 52

Clinical Trials Clinical Research Trials Research 52

Drug Discovery World

JUNE 9, 2023

RemeGen announced the latest clinical research results on disitamab vedotin (RC48) at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. Researchers tested disitamab vedotin and toripalimab in combination on patients diagnosed with locally advanced or metastatic urothelial carcinoma (la/mUC).

Clinical Research 130

Clinical Research Hospitals Treatment Research 130

Advarra

MARCH 10, 2023

Considered a rare disease, research in finding better therapies – and possibly even a cure – for SCD may be competing for funding with conditions impacting broader populations. SCD’s significant impact on African Americans also means it predominantly impacts a minority community historically underserved by clinical research.

Disease 98

Disease Clinical Trials Doctors Trials 98

Vial

APRIL 10, 2024

The increasing costs associated with in-house drug development have prompted biotech and pharmaceutical companies to increasingly outsource to contract research organization s (CROs) for assistance. The company reported a revenue of $11,116 million for the first nine months of 2023, marking a 4.2% increase on a reported basis and an 4.8%

Clinical Trials 52

Clinical Trials Trials Compliance Clinical Research 52

Alta Sciences

JULY 28, 2023

jpg Tags Clinical Trials Preclinical Research Bioanalysis Weight 10 Listen to the audiobook >>> Issue 32 — A Changing Paradigm for Non-rodent Species in Nonclinical Safety Studies Discover the increasing body of evidence that supports the use of miniature swine as a viable option for your small and large molecule studies.

Science 52

Science Clinical Research Clinical Trials Drug Development 52

Alta Sciences

JUNE 16, 2023

An Overview of Health Canada's CTA Process rmaloney Mon, 06/19/2023 - 16:30 HTML Watch this podcast in which Altasciences' regulatory experts share key insights on Health Canada's Clinical Trial Application (CTA) regulatory submission process, including answers to your most common questions.

Clinical Trials 52

Clinical Trials Clinical Research Trials Research 52